LCID
Lucid Group, Inc.
LCID has a slight edge over NCLH overall, supported by stronger fundamentals and stronger modeled upside.
NCLH
Norwegian Cruise Line Holdings Ltd.
NCLH has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NCLH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Weak |
NCLH's profitability is currently healthy, and its revenue is stable, but its cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NCLH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.7x | $18.06 | — |
| Cheap | 9.9x | $18.49 | +2.4% |
| Forward | 14x | $18.06 | — |
| Fair | 16x | $29.39 | +63% |
| Expensive | 22x | $40.83 | +126% |
Historical ranges are pointers, not guarantees.
NCLH's PE is in its cheap range at 9.7x. Analysts expect earnings to fall, which would put today's price at 14x next year's earnings, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NCLH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect NCLH's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
NCLH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.26 | -32% |
| Q3 2026 | $1.86 | +34% |
| Q2 2026 | $1.65 | +11% |
| Q1 2026 | $1.24 | -30% |
| Q4 2025 | $0.92 | -51% |
| Q3 2025 | $1.39 | +16% |
| Q2 2025 | $1.48 | +54% |
| Q1 2025 | $1.76 | +117% |
| Q4 2024 | $1.89 | +385% |
NCLH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over NCLH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
NCLH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.9B | +0.3% |
| Q2 2026 | $2.6B | +4.9% |
| Q1 2026 | $2.3B | +9.6% |
| Q4 2025 | $2.2B | +6.4% |
| Q3 2025 | $2.9B | +4.7% |
| Q2 2025 | $2.5B | +6.1% |
| Q1 2025 | $2.1B | -2.9% |
| Q4 2024 | $2.1B | +6.2% |
NCLH's revenue has grown year over year for six quarters in a row: $2.9B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -4.3 points |
| Q2 2026 | 14% | -3.1 points |
| Q1 2026 | 10% | +0.6 points |
| Q4 2025 | 8.3% | -1.9 points |
| Q3 2025 | 26% | +0.9 points |
| Q2 2025 | 17% | +2.4 points |
| Q1 2025 | 9.4% | -0.5 points |
| Q4 2024 | 10% | +3.9 points |
NCLH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NCLH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.4M | +$621.2M |
| Q2 2026 | $144.9M | -62% |
| Q1 2026 | -$625.2M | +$220.8M |
| Q4 2025 | $21.5M | -86% |
| Q3 2025 | -$726.5M | -$531M |
| Q2 2025 | $381.2M | +15% |
| Q1 2025 | -$846M | -254% |
| Q4 2024 | $155.8M | +$544.5M |
NCLH has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
NCLH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -3.5M shares |
| 1 year | -7.1% | -35.3M shares |
| 3 years | -10% | -51.2M shares |
| 5 years | +24% | +90.4M shares |
| Available history | +113% | +244M shares |
NCLH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NCLH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.7x | High |
| Q2 2026 | 5.5x | High |
| Q1 2026 | 5.5x | High |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 5.6x | High |
| Q2 2025 | 5.5x | High |
| Q1 2025 | 5.8x | High |
| Q4 2024 | 5.4x | High |
NCLH's net debt is about 5.7 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NCLH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 62.4 | Neutral |
NCLH's weekly RSI is 53 (neutral) and its Stochastic is 62 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NCLH PE vs Consumer Cyclical Sector
| Metric | NCLH | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 18x | 46% below |
| PE % | 15 | 47 | 32 pts below |
NCLH is trading at 9.7x earnings, a 46% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NCLH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.1 | 12% above |
| 20 week MA | $17.1 | 5.5% above |
| 50 week MA | $19.1 | 5.4% below |
| 100 week MA | $20.6 | 12% below |
| 200 week MA | $19.2 | 6.1% below |
NCLH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
NCLH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.1 | $24.6 | -58% |
| 2021 | $24.6 | $22.7 | -7.6% |
| 2022 | $22.7 | $13.0 | -43% |
| 2023 | $13.0 | $20.0 | +54% |
| 2024 | $20.0 | $25.8 | +28% |
| 2025 | $25.8 | $22.8 | -11% |
| 2026 YTD | $22.8 | $18.1 | -21% |
NCLH has the edge over LCID on returns for 2026, with the stronger performance.